Cerebral Protection Devices during TAVR in the Daily Practice

The theory behind the use of cerebral protection devices during TAVR is good, but hard to test. The daily practice provides a far bigger number of patients, and therefore might be able to better show how to prevent one of the hardest events during TAVR. 

La protección cerebral en TAVI continúa con evidencia débil pero con esperanzas

This study resorted to Germany’s TAVR database between 2015 and 2017, with over 40,000 patients, and looked into patients who had received a cerebral protection device during procedure. 

Cerebral protection devices were used only in 3.8% of patients who were younger, compared against the rest, but had higher surgical risk.

Propensity score was used to compare patients receiving cerebral protection devices vs. patients not receiving any. 

After adjusting, it was observed that the use of a cerebral protection device will not reduce the risk of stroke (p=0.069) or delirium after procedure (p=0.106). Delirium is interpreted as a sign of acute cerebral compromise. 


Read also: Thrombocytopenia and Thrombosis May Be Linked to AstraZeneca Vaccine, Analysis Reports.


What is curious is that even though researchers were no able to prevent stroke, they did see a drop in inhospital mortality with the use of protection devices (p=0.034). This reduction in mortality is difficult to explain from the physiopathological point of view and calls for further research. 

Conclusion

In this huge database, we observe that the use of cerebral protection devices during TAVR is fairly infrequent in the daily practice. Cerebral protection devices did not reduce the risk of stroke or delirium. 

j-jcin-2020-09-047free

Original Title: The Use and Outcomes of Cerebral Protection Devices for Patients Undergoing Transfemoral Transcatheter Aortic Valve Replacement in Clinical Practice.

Reference: Peter Stachon et al. J Am Coll Cardiol Intv 2021;14:161–8. https://doi.org/10.1016/j.jcin.2020.09.047.


Subscribe to our weekly newsletter

Get the latest scientific articles on interventional cardiology

More articles by this author

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...

J-Valve for Chronic AR: 30-Day Outcomes of Transfemoral Valve J-Valve in Chronic Aortic Regurgitation

Chronic aortic regurgitation (AR) poses a significant challenge as far as transcatheter alternatives go due to the absence of calcification and a suitable anchoring...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Related Articles

SOLACI Sessionsspot_img

Recent Articles

Long Term Results of the International Chimney Registry

The International Chimney Registry was an observational study aimed at assessing the use of chimney stenting during TAVR either to predict or treat coronary...

CANNULATE TAVR extended study: Impact of Commissural and Coronary Alignment in Coronary Cannulation Following TAVR with Evolut Fx

The new valve Evolut FX has shown better commissural alignment vs. its predecessor Evolut Pro+. Prior studies have already shown commissure alignment facilitates post...

TRISCEND II: Transcatheter Replacement vs. Medical Treatment for Tricuspid Regurgitation

The EVOQUE device is designed with an intra-annular sealing system that provides excellent anatomical compatibility and an adaptable shape. It is currently available in...